Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
52.87
+0.05 (0.09%)
At close: May 1, 2026, 4:00 PM EDT
52.60
-0.27 (-0.52%)
After-hours: May 1, 2026, 7:39 PM EDT
Soleno Therapeutics Market Cap
Soleno Therapeutics has a market cap or net worth of $2.73 billion as of May 1, 2026. Its market cap has decreased by -14.73% in one year.
Market Cap
2.73B
Enterprise Value
2.28B
1-Year Change
-14.73%
Ranking
Category
Stock Price
$52.87
Market Cap Chart
Since November 13, 2014, Soleno Therapeutics's market cap has increased from $24.70M to $2.73B, an increase of 10,970.20%. That is a compound annual growth rate of 50.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 2.73B | 9.76% |
| Dec 31, 2025 | 2.49B | 28.31% |
| Dec 31, 2024 | 1.94B | 57.88% |
| Dec 29, 2023 | 1.23B | 7,477.78% |
| Dec 30, 2022 | 16.20M | -50.46% |
| Dec 31, 2021 | 32.70M | -78.72% |
| Dec 31, 2020 | 153.70M | 17.06% |
| Dec 31, 2019 | 131.30M | 257.77% |
| Dec 31, 2018 | 36.70M | 103.89% |
| Dec 29, 2017 | 18.00M | 40.63% |
| Dec 30, 2016 | 12.80M | -44.10% |
| Dec 31, 2015 | 22.90M | 126.73% |
| Dec 31, 2014 | 10.10M | -59.11% |
| Nov 13, 2014 | 24.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcutis Biotherapeutics | 2.92B |
| Nektar Therapeutics | 2.92B |
| Denali Therapeutics | 2.90B |
| Dyne Therapeutics | 2.87B |
| Kodiak Sciences | 2.73B |
| Tarsus Pharmaceuticals | 2.71B |
| Immunome | 2.57B |
| Disc Medicine | 2.55B |